Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Molecules ; 27(9)2022 Apr 20.
Artículo en Inglés | MEDLINE | ID: mdl-35565992

RESUMEN

Chronic rhinosinusitis (CRS) is characterized by chronic inflammation of the sinonasal mucosa with epithelial dedifferentiation toward the mesenchymal phenotype, known as the epithelial-mesenchymal transition (EMT). Asian sand dust (ASD) can induce nasal mucosal inflammation and cause the development of EMT. Korean red ginseng (KRG) and ginsenoside Rg3 have been used as traditional herbal medicines to treat various diseases. The aim of this study was to investigate their effect on ASD-induced EMT in nasal epithelial cells. Primary nasal epithelial cells were incubated with ASD with or without KRG or Rg3, and the production of transforming growth factor-ß1 (TGF-ß1) and interleukin (IL)-8 was measured. EMT markers were determined by RT-PCR, Western blot analysis, and confocal microscopy, and transcription factor expression by Western blot analysis. The effect on cell migration was evaluated using the wound scratch assay. Results showed ASD-induced TGF-ß1 production, downregulation of E-cadherin, and upregulation of fibronectin in nasal epithelial cells. KRG and Rg3 suppressed TGF-ß1 production (31.7% to 43.1%), upregulated the expression of E-cadherin (26.4% to 88.3% in mRNA), and downregulated that of fibronectin (14.2% to 46.2% in mRNA and 52.3% to 70.2% in protein). In addition, they suppressed the ASD-induced phosphorylation of ERK, p38, and mTOR, as well as inhibiting the ASD-induced migration of nasal epithelial cells (25.2% to 41.5%). The results of this study demonstrate that KRG and Rg3 inhibit ASD-induced EMT by suppressing the activation of ERK, p38, and mTOR signaling pathways in nasal epithelial cells.


Asunto(s)
Transición Epitelial-Mesenquimal , Panax , Cadherinas/metabolismo , Movimiento Celular , Polvo , Células Epiteliales , Fibronectinas/metabolismo , Ginsenósidos , Humanos , Inflamación/metabolismo , Panax/metabolismo , ARN Mensajero/metabolismo , Arena , Serina-Treonina Quinasas TOR/metabolismo , Factor de Crecimiento Transformador beta1/metabolismo
2.
Poult Sci ; 100(8): 101276, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-34229219

RESUMEN

The present study investigated the effect of dietary soluble flaxseed oil (SFO), as a source of omega-3 polyunsaturated fatty acids, on the fatty acid composition of egg yolk and various indices including laying performance, egg quality, nutrient composition of eggs, egg stability upon storage, and serum characteristics in laying hens. A total of 210 52-week-old Hy-Line Brown laying hens were assigned to one of 5 experimental diets. A corn-soybean meal-based control diet was mixed without or with SFO to reach the concentrations of 0.2, 0.4, 0.6, and 0.8% in diets and fed for 4 wk. Dietary SFO did not affect laying performance and egg quality. Increasing dietary SFO linearly increased the pH of yolk at 7, 14, and 28 d following storage at room temperature (P < 0.05). Malondialdehyde contents in egg yolks were quadratically increased (P < 0.05) at 0, 7, and 21 d following storage as the inclusion levels of SFO increased in diets. A significant increase (P < 0.05) in total omega-3 polyunsaturated fatty acids and docosahexaenoic acid, but not α-linolenic acid and eicosapentaenoic acid, was deposited in egg yolks at 2 and 4 wk following the SFO feeding. Finally, dietary SFO did not affect serum parameters such as total cholesterol, triglyceride, high-density lipoprotein cholesterol, and nitric oxide. It is concluded that adding SFO into the diets of laying hens can be an efficient strategy to enrich the omega-3 polyunsaturated fatty acids, including docosahexaenoic acid in eggs.


Asunto(s)
Ácidos Grasos Omega-3 , Lino , Alimentación Animal/análisis , Animales , Pollos , Dieta/veterinaria , Suplementos Dietéticos , Yema de Huevo , Ácidos Grasos , Femenino , Óvulo
3.
Molecules ; 26(7)2021 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-33916022

RESUMEN

Korean Red ginseng (KRG), commonly used in traditional medicine, has anti-inflammatory, anti- oxidative, and anti-tumorigenic properties. Asian sand dust (ASD) is known to aggravate upper and lower airway inflammatory responses. BEAS-2B cells were exposed to ASD with or without KRG or ginsenoside Rg3. Mucin 5AC (MUC5AC), MUC5B, and MUC8 mRNA and protein expression levels were determined using quantitative RT-PCR and enzyme-linked immunosorbent assay. Nuclear factor kappa B (NF-κB), activator protein 1, and mitogen-activated protein kinase expression and activity were determined using western blot analysis. ASD induced MUC5AC, MUC5B, and MUC8 mRNA and protein expression in BEAS-2B cells, which was significantly inhibited by KRG and Rg3. Although ASD-induced mucin expression was associated with NF-κB and p38 mitogen-activated protein kinase (MAPK) activity, KRG and Rg3 significantly suppressed only ASD-induced NF-κB expression and activity. KRG and Rg3 inhibited ASD-induced mucin gene expression and protein production from bronchial epithelial cells. These results suggest that KRG and Rg3 have potential for treating mucus-producing airway inflammatory diseases.


Asunto(s)
Polvo , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Regulación de la Expresión Génica , Ginsenósidos/farmacología , Mucinas/genética , Panax/química , Arena , Línea Celular , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Ginsenósidos/química , Humanos , Estructura Molecular , Mucina 5AC/biosíntesis , Mucina 5AC/genética , Mucina 5B/biosíntesis , Mucina 5B/genética , Mucinas/biosíntesis , Mucosa Respiratoria/efectos de los fármacos , Mucosa Respiratoria/metabolismo
4.
Nutrients ; 12(10)2020 Oct 11.
Artículo en Inglés | MEDLINE | ID: mdl-33050586

RESUMEN

BACKGROUND: Fatigue is one of the major health conditions induced by excessive stress or abnormal immune function or defective antioxidant systems. Placental extract has been reported to have various effects such as immune modulation and cellular regeneration. Fermented porcine placenta (FPP) is a safe nontoxic material, which is highly valuable as a functional food. The aim of this study was to investigate the anti-fatigue effects of FPP supplementation compared with a placebo product. METHODS: In this double-blind, parallel, randomized, and placebo-controlled trial 84 healthy males and females, aged between 30 and 60 years were randomized to 320 mg of FPP once daily or placebo. The main outcome measures included efficacy of fatigue-inducing treadmill exercise on physical fatigue and fatigue-related parameters based on the questionnaire administered. RESULTS: The IL-1ß mRNA expression and fatigue severity scale were changed significantly after 8 weeks of treatment with fermented porcine placenta compared with placebo (p < 0.05). Cortisol levels were significantly improved in participants younger than 45 years following treatment with FPP compared with placebo. Furthermore, the lactate and myoglobin levels were improved significantly in participants with BMI ≥ 23 kg/m2 (p = 0.045 and p = 0.011, respectively) following treatment with FPP versus placebo. CONCLUSIONS: Our study showed that FPP supplementation significantly ameliorated fatigue-related parameters and subjective symptoms in healthy adults. Therefore, our results indicate that FPP supplementation induced anti-fatigue effect by regulating the inflammatory response.


Asunto(s)
Suplementos Dietéticos , Fatiga/metabolismo , Fatiga/terapia , Extractos Placentarios/administración & dosificación , Adulto , Animales , Método Doble Ciego , Fatiga/genética , Fatiga/prevención & control , Femenino , Fermentación , Humanos , Hidrocortisona/metabolismo , Interleucina-1beta/genética , Interleucina-1beta/metabolismo , Lactatos/metabolismo , Masculino , Persona de Mediana Edad , Mioglobina/metabolismo , Extractos Placentarios/farmacología , ARN Mensajero/genética , ARN Mensajero/metabolismo , Encuestas y Cuestionarios , Porcinos , Resultado del Tratamiento
5.
Molecules ; 25(19)2020 Oct 02.
Artículo en Inglés | MEDLINE | ID: mdl-33023110

RESUMEN

The present study aims to investigate the immunomodulatory effects of essential oil from Chamaecyparis obtusa (EOCO) in an ovalbumin (OVA)-induced allergic rhinitis (AR) mouse model. BALB/c mice were intraperitoneally sensitized and stimulated with OVA. From day 22 to 35, 0.01% and 0.1% ECOC was intranasally administered 1 h before OVA stimulation. Nasal symptoms, as well as serum total and OVA-specific immunoglobulin (Ig) E levels, were measured. Interleukin (IL)-4, IL-10, interferon (IFN)-γ, and tumor necrosis factor (TNF)-α levels in nasal lavage fluid (NLF) and their production by activated splenocytes were measured. Histological changes in the sinonasal mucosa were evaluated through hematoxylin and eosin and periodic acid-Schiff staining procedure. Th cytokines and their transcription factor mRNA expressions were determined using reverse-transcription polymerase chain reaction. Intranasal EOCO administration significantly suppressed allergic symptoms, OVA-specific IgE level, sinonasal mucosal inflammatory cell infiltration, and mucus-producing periodic acid-Schiff (PAS) positive cell count. EOCO also significantly inhibited IL-4, IL-10, and TNF-α levels in NLF and activated splenocytes. Th2 and Treg related cytokines and their transcription factors in sinonasal mucosa were significantly suppressed through intransal EOCO instillation. In conclusion, repetitive EOCO intranasal instillation showed anti-inflammatory and anti-allergic effects by suppressing nasal symptoms and inhibiting the production and expression of inflammatory mediators in the OVA-induced AR mouse model.


Asunto(s)
Chamaecyparis/química , Factores Inmunológicos/uso terapéutico , Aceites Volátiles/uso terapéutico , Rinitis Alérgica/tratamiento farmacológico , Animales , Modelos Animales de Enfermedad , Femenino , Inmunoglobulina E/sangre , Factores Inmunológicos/farmacología , Mediadores de Inflamación/metabolismo , Ratones Endogámicos BALB C , Líquido del Lavado Nasal , Mucosa Nasal/efectos de los fármacos , Mucosa Nasal/patología , Aceites Volátiles/farmacología , Ovalbúmina/inmunología , Rinitis Alérgica/sangre , Bazo/patología , Factores de Transcripción/metabolismo
7.
J Cosmet Dermatol ; 17(6): 1053-1058, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30280474

RESUMEN

BACKGROUND: Melasma is a common acquired facial pigmentary disorder that is resistant to various modalities of treatment. Recently, the low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser (QSNY) has emerged as the new gold standard of melasma treatment in Asia. OBJECTIVE: To evaluate the efficacy and safety of low-fluence 1064-nm QSNY in Asian patients with melasma. METHODS: Data of patients with melasma treated with low-fluence QSNY in the department of dermatology at the Korea University Anam Hospital were reviewed retrospectively. A 1064-nm QSNY with 8 mm spot size and fluence of 1.2-2.0 J/cm2 at 10 Hz was used. The results were evaluated using the modified Melasma Area and Severity Index (mMASI) score and the physician's global assessment (PGA). RESULTS: A total of 40 Korean patients with Fitzpatrick skin type III to IV were included. Patients were treated for a median of 10 sessions at a median of 1-week intervals. The mean mMASI score decreased by 54.23% from a baseline of 3.19 ± 2.64 to 1.46 ± 1.06 after treatment. On PGA, 1 out of 40 patients (2.5%) showed excellent improvement, 14 (35%) good, 15 (37.5%) fair, 6 (15%) poor, and 4 (10%) no improvement. However, two patients showed mottled hypopigmentation and rebound hyperpigmentation. CONCLUSION: Low-fluence 1064-nm QSNY appears to be a safe and effective treatment for Asian patients with melasma.


Asunto(s)
Láseres de Estado Sólido/uso terapéutico , Terapia por Luz de Baja Intensidad/métodos , Melanosis/radioterapia , Adulto , Anciano , Anciano de 80 o más Años , Pueblo Asiatico , Femenino , Humanos , Hipopigmentación/etiología , Láseres de Estado Sólido/efectos adversos , Terapia por Luz de Baja Intensidad/efectos adversos , Masculino , Persona de Mediana Edad , República de Corea , Estudios Retrospectivos , Índice de Severidad de la Enfermedad
8.
Neurosci Lett ; 668: 73-79, 2018 03 06.
Artículo en Inglés | MEDLINE | ID: mdl-29329911

RESUMEN

Neuropeptide Y (NPY) is an evolutionarily conserved neuropeptide implicated in feeding regulation in vertebrates. In mammals, NPY neurons coexpress Agouti-related protein (AgRP) in the arcuate nucleus of the hypothalamus, and NPY/AgRP neurons activate orexigenic signaling to increase food intake. Zebrafish express npy and two agrp genes, agrp1 and agrp2, in the brain. Similar to mammals, NPY and AgRP1 act as orexigenic factors in zebrafish, but the exact distribution of NPY and AgRP neurons in the zebrafish brain and the regulation of these genes by metabolic states remain unclear. In this study, we analyzed the tissue distribution of npy, agrp1, and agrp2 mRNA in the brain of larval and adult zebrafish. We detected the expression of agrp1, but not npy, in the hypothalamus of larval zebrafish. In the adult zebrafish brain, npy mRNA expression was detected in the dorsal area of the periventricular and lateral hypothalamus, but fasting induced upregulation of npy only in the lateral hypothalamus, indicating that NPY neurons in this area are implicated in feeding regulation. However, consistent with the findings in larval zebrafish, NPY neurons in the hypothalamus did not coexpress AgRP1. In contrast, fasting resulted in a dramatic increase in AgRP1 neurons in the ventral periventricular hypothalamus, which do not coexpress NPY. In addition, we found for the first time that npy- and agrp1-expressing neurons function as GABAergic inhibitory neurons in zebrafish, as they do in mammals. Taken together, our results show that the zebrafish NPY/AgRP system is involved in appetite regulation. In addition, our data suggest that although npy and agrp1 were initially expressed in distinct neurons, evolution has resulted in their coexpression in mammalian hypothalamic neurons.


Asunto(s)
Proteína Relacionada con Agouti/metabolismo , Regulación del Apetito/fisiología , Hipotálamo/metabolismo , Neuropéptido Y/metabolismo , ARN Mensajero/metabolismo , Proteínas de Pez Cebra/metabolismo , Pez Cebra/metabolismo , Animales , Femenino , Larva/metabolismo , Masculino
9.
Medicine (Baltimore) ; 96(39): e8135, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28953648

RESUMEN

RATIONALE: Although trigger point injection is known as an easy and low-risk procedure, it is contraindicated to patients with hemorrhagic disorders or who regularly take anticoagulants/antiplatelets. However, taking clopidogrel is not a defined contraindication to this low-risk procedure. PATIENT CONCERNS: The chief complaint of a 76-year old woman regularly taking clopidogrel was low back and left buttock pain which prolonged for several years. DIAGNOSES: The patient was diagnosed with L4-5 and L5-S1 spinal stenosis at the orthopedics department and was referred for lumbar spinal epidural steroid injection. INTERVENTION: She was treated with trigger point injection. OUTCOMES: Three hours after the injection, she complained motor weakness and pain in the injection area. A hematoma on left gluteus medium muscle was detected with ultrasonography and ultrasound-guided needle aspiration was accomplished to relieve the symptom. LESSONS: Trigger point injection for patients taking clopidogrel should be done with a caution to prevent such complication.


Asunto(s)
Biopsia con Aguja Fina/métodos , Glucocorticoides/administración & dosificación , Hematoma , Inyecciones Epidurales , Dolor de la Región Lumbar/tratamiento farmacológico , Estenosis Espinal/complicaciones , Ticlopidina/análogos & derivados , Anciano , Nalgas/diagnóstico por imagen , Clopidogrel , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/diagnóstico , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/etiología , Femenino , Hematoma/diagnóstico , Hematoma/etiología , Hematoma/fisiopatología , Humanos , Biopsia Guiada por Imagen , Inyecciones Epidurales/efectos adversos , Inyecciones Epidurales/métodos , Dolor de la Región Lumbar/etiología , Debilidad Muscular/diagnóstico , Debilidad Muscular/etiología , Músculo Esquelético/diagnóstico por imagen , Músculo Esquelético/patología , Inhibidores de Agregación Plaquetaria/uso terapéutico , Estenosis Espinal/diagnóstico , Ticlopidina/uso terapéutico , Resultado del Tratamiento , Puntos Disparadores , Ultrasonografía/métodos
10.
Food Chem Toxicol ; 106(Pt A): 367-375, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28564614

RESUMEN

Natural plant oils have been used as a translational alternative to modern medicine. Particularly, virgin coconut oil (VCO) has gained popularity because of its potential benefits in pharmaceutical, nutritional, and cosmetic applications. Cultured coconut extract (CCE) is an alternative end product of VCO, which undergoes a further bacterial fermentation process. This study aimed to investigate the effects of CCE on human skin. We analyzed the expression of skin barrier molecules and collagens after applying CCE on human explanted skin. To evaluate the anti-inflammatory properties of CCE, the expression of inflammatory markers was analyzed after ultraviolet B (UVB) irradiation. The CCE-treated group showed increased expression of cornified cell envelope components, which contribute to protective barrier functions of the stratum corneum. Further, the expression of inflammatory markers was lower in the CCE-treated group after exposure to UVB radiation. These results suggest an anti-inflammatory effect of CCE against UVB irradiation-induced inflammation. Additionally, the CCE-treated group showed increased collagen and hyaluronan synthase-3 expression. In our study, CCE showed a barrier-enhancing effect and anti-inflammatory properties against ex vivo UVB irradiation-induced inflammation. The promising effect of CCE may be attributed to its high levels of polyphenols and fatty acid components.


Asunto(s)
Antiinflamatorios/farmacología , Cocos/química , Extractos Vegetales/farmacología , Aceites de Plantas/farmacología , Piel/efectos de los fármacos , Adulto , Antiinflamatorios/análisis , Aceite de Coco , Colágeno/metabolismo , Humanos , Persona de Mediana Edad , Extractos Vegetales/análisis , Aceites de Plantas/análisis , Polifenoles/análisis , Polifenoles/farmacología , Piel/metabolismo , Piel/efectos de la radiación , Rayos Ultravioleta
11.
Arch Pharm Res ; 35(11): 1999-2006, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23212642

RESUMEN

In this study, we evaluated the effects of silicone-based gel on the healing of hypertrophic scars in the rabbit ear model. After 4-week application of silicone-based gel containing allantoin, dexpanthenol and heparin (Noscarna™) to scars in a rabbit ear model of hypertrophic scarring, significant improvements in hypertrophic scar healing and a great loss of skin pigment were observed compared to the non-treated control, base or silicone control-treated scars. Furthermore, histological analysis of Noscarna™-treated scars revealed a significant reduction in scar elevation index (SEI), anterior skin and epithelial thicknesses, inflammatory cells, vessels, collagen disorganization and fibroblasts compared to all control hypertrophic scars. Furthermore, Noscarna™ showed more favorable effects on hypertrophic scars than a commercial product, Contractubex®. Therefore, these results clearly demonstrated that the newly developed silicone-based gel, Noscarna™, could be a promising formulation as an effective therapeutic agent for hypertrophic scars.


Asunto(s)
Alantoína/farmacología , Cicatriz Hipertrófica/tratamiento farmacológico , Heparina/farmacología , Ácido Pantoténico/análogos & derivados , Alantoína/administración & dosificación , Animales , Cicatriz Hipertrófica/patología , Modelos Animales de Enfermedad , Combinación de Medicamentos , Femenino , Heparina/administración & dosificación , Ácido Pantoténico/administración & dosificación , Ácido Pantoténico/farmacología , Extractos Vegetales/administración & dosificación , Extractos Vegetales/farmacología , Conejos , Geles de Silicona/química , Piel/efectos de los fármacos , Piel/metabolismo , Piel/patología , Pigmentación de la Piel/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA